(A) Day-6 BMDCs from either WT or Mfge8–/– mice were incubated with Apo-OVA for 24–36 hours. Recombinant MFG-E8 was mixed with apoptotic cells before adding to Mfge8–/– BMDCs at a final concentration of 0.2 μg/ml. Apo-OVA–containing BMDCs were collected to stimulate CFSE–labeled OT-I CD8+ T cells with total DC/T ratios of 1:1 and 3:1. OT-I T cell proliferation and CD62L downregulation were analyzed by flow cytometry at day 3. The results from 2 out of 3 independent experiments are shown. Right: division indices from 3 independent experiments **P = 0.05, *P = 0.08, ****P = 0.025, ***P = 0.04, paired t test. (B) As controls, BMDCs were incubated with either OVA peptide (10 μM) for 1 hour or with soluble OVA protein (200 μg/ml) overnight. After washing with medium, DCs were used to stimulate OT-I T cells (red, Mfge8–/– BMDCs; green, Mfge8–/– BMDCs plus rMFG-E8; blue, WT BMDCs). Both control experiments were performed twice with similar results.